OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance
Mehrdad Hashemi, Shima Hajimazdarany, Chakrabhavi Dhananjaya Mohan, et al.
Pharmacological Research (2022) Vol. 186, pp. 106535-106535
Closed Access | Times Cited: 28
Mehrdad Hashemi, Shima Hajimazdarany, Chakrabhavi Dhananjaya Mohan, et al.
Pharmacological Research (2022) Vol. 186, pp. 106535-106535
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1141-1200
Closed Access | Times Cited: 98
Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1141-1200
Closed Access | Times Cited: 98
miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses
Hesham A. El-Mahdy, Ahmed M. Mohamadin, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154457-154457
Closed Access | Times Cited: 51
Hesham A. El-Mahdy, Ahmed M. Mohamadin, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154457-154457
Closed Access | Times Cited: 51
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 50
Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114392-114392
Open Access | Times Cited: 50
Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal
Suneel Kumar, Stephen O. Mathew, Ravindra Prasad Aharwal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 160-160
Open Access | Times Cited: 25
Suneel Kumar, Stephen O. Mathew, Ravindra Prasad Aharwal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 160-160
Open Access | Times Cited: 25
Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers
Maliheh Entezari, Ghazaleh Gholamiyan Yousef Abad, Behnaz Sedghi, et al.
Environmental Research (2023) Vol. 225, pp. 115673-115673
Closed Access | Times Cited: 22
Maliheh Entezari, Ghazaleh Gholamiyan Yousef Abad, Behnaz Sedghi, et al.
Environmental Research (2023) Vol. 225, pp. 115673-115673
Closed Access | Times Cited: 22
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 21
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 21
Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma
Peng Wang, Yanling Li, Bin Cheng, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107975-107975
Open Access | Times Cited: 4
Peng Wang, Yanling Li, Bin Cheng, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107975-107975
Open Access | Times Cited: 4
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 4
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 4
Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 25
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 25
Nanoliposomes as nonviral vectors in cancer gene therapy
Ş. Yildiz, Maliheh Entezari, Mahshid Deldar Abad Paskeh, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
Ş. Yildiz, Maliheh Entezari, Mahshid Deldar Abad Paskeh, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 3
The potential relevance of long non-coding RNAs in colorectal cancer pathogenesis and treatment: A review focus on signaling pathways
Ahmed S. Doghish, Mohamed Bakr Zaki, Mahmoud Gomaa Eldeib, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155044-155044
Closed Access | Times Cited: 10
Ahmed S. Doghish, Mohamed Bakr Zaki, Mahmoud Gomaa Eldeib, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155044-155044
Closed Access | Times Cited: 10
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies
Sabrean Farhan Jawad, Farag M. A. Altalbawy, Radhwan M. Hussein, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 5-27
Closed Access | Times Cited: 9
Sabrean Farhan Jawad, Farag M. A. Altalbawy, Radhwan M. Hussein, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 5-27
Closed Access | Times Cited: 9
METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
Zhiyang Zhou, Yukun Cao, Yuan Yang, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Zhiyang Zhou, Yukun Cao, Yuan Yang, et al.
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 9
Multi-omics analysis of DNA replication-associated primase polymerase (PRIMPOL) in pan-cancer: a potential target for prognosis and immune response
Langmei Deng, Abhimanyu Thakur, Jinwu Peng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Langmei Deng, Abhimanyu Thakur, Jinwu Peng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154902-154902
Closed Access | Times Cited: 8
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154902-154902
Closed Access | Times Cited: 8
The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 6
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 6
A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma
Yue Yuan, Jie Tao, Dan An, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24462-e24462
Open Access | Times Cited: 1
Yue Yuan, Jie Tao, Dan An, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24462-e24462
Open Access | Times Cited: 1
T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies
Fatma Ozsoy, Mahir M. Sharif, Nasrullah Jan, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 2637-2659
Open Access | Times Cited: 1
Fatma Ozsoy, Mahir M. Sharif, Nasrullah Jan, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 2637-2659
Open Access | Times Cited: 1
Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
Yunfang Yu, Gengyi Cai, Ruichong Lin, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 1
Yunfang Yu, Gengyi Cai, Ruichong Lin, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 1
LncRNA FAM83A-AS1 promotes epithelial–mesenchymal transition of pancreatic cancer cells via Hippo pathway
Huizhi Wang, Yuntao Ding, Qiuming Zhu, et al.
Cell Cycle (2023) Vol. 22, Iss. 12, pp. 1514-1527
Open Access | Times Cited: 4
Huizhi Wang, Yuntao Ding, Qiuming Zhu, et al.
Cell Cycle (2023) Vol. 22, Iss. 12, pp. 1514-1527
Open Access | Times Cited: 4
The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
Jie Yuan, Yang Li, Zhi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Jie Yuan, Yang Li, Zhi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
Zheng Zhou, Yusong Zhou, Wei Liu, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Zheng Zhou, Yusong Zhou, Wei Liu, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Xue Zhang, Guang‐Yu Guo, Ru‐Yue Liu, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 21, pp. 3271-3285
Open Access | Times Cited: 2
miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition
Ying Ma, Yiru Wang, Can Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Ying Ma, Yiru Wang, Can Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Continued attention: The role of exosomal long non-coding RNAs in tumors over the past three years
Jiarui Cao, Bo Feng, Yanchao Xv, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113666-113666
Open Access
Jiarui Cao, Bo Feng, Yanchao Xv, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113666-113666
Open Access
